SCHEMBL5262875

SCHEMBL5262875

O=Cc1cc2c(c([N+](=O)[O-])c1)OCC(=O)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.41
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
VCAM1 P19320 1/20 0.38
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
ALDH1A3 P47895 1/20 0.36
RAB9A P51151 1/20 0.35
PDE3B Q13370 2/20 0.34
PDE3A Q14432 2/20 0.34
ALDH3A1 P30838 2/20 0.33
PGR P06401 2/20 0.33
POLB P06746 1/20 0.33
MMP12 P39900 1/20 0.33
NR3C2 P08235 3/20 0.33
GSK3B P49841 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
PARP1 P09874 1/20 0.32
NR3C1 P04150 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31731496 0.80 PGR (0.37) VCAM1ALDH1A1MAPTRAB9APDE3B
SCHEMBL252672 0.80 PGR (0.37) VCAM1ALDH1A1MAPTRAB9APDE3B
SCHEMBL5340556 0.78 IL4I1 (0.43) ALDH1A1MAPTPDE3BPDE3APGR
SCHEMBL29952529 0.77 NR3C2 (0.44) PDE3BPDE3APGRMMP12NR3C2
SCHEMBL5345549 0.77 NR3C2 (0.43) ALDH1A1MAPTPDE3BPDE3APGR
SCHEMBL3276712 0.77 NR3C2 (0.44) PDE3BPDE3APGRMMP12NR3C2
SCHEMBL3598751 0.74 RAB9A (0.45) XDHALDH1A1MAPTRAB9APOLB
SCHEMBL532299 0.73 ALDH1A1 (0.39) ALDH5A1ABATALDH1A1MAPTRAB9A
SCHEMBL20265314 0.70 ALDH1A1 (0.44) ALDH1A1MAPTPDE3BPDE3APGR
SCHEMBL4625398 0.69 TXNRD1 (0.51) XDHALDH5A1ABATVCAM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399443-B1 NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2007-12-12 EP disclosed
US-20070135422-A1 Nitrogen-containing bicycle heterocycles for use as antibacterials SMITHKLINE BEECHAM P.L.C. 2007-06-14 US disclosed
US-7141564-B2 Nitrogen-containing bicyclic heterocycles for use as antibacterials SMITHKLINE BEECHAM P.L.C. (GB) 2006-11-28 US disclosed
US-20040171620-A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials SMITHKLINE BEECHAM P.L.C. (GB) 2004-09-02 US disclosed
EP-1399443-A1 NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2004-03-24 EP disclosed
WO-2003087098-A1 NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS SMITHKLINE BEECHAM P.L.C. (GB) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171620-A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials NRDC, NUCB2, NDC1 XDH 342/4885ALDH5A1 1170/4885ABAT 203/4885
US-20070135422-A1 Nitrogen-containing bicycle heterocycles for use as antibacterials NRDC, NUCB2, NISCH XDH 430/4885ALDH5A1 1150/4885ABAT 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.